Skip to main content
. 2016 May 19;9(19):14791–14802. doi: 10.18632/oncotarget.9462

Figure 3. Octreotide-induced inhibition of forskolin-stimulated cAMP production.

Figure 3

Octreotide-induced inhibition of forskolin-stimulated cAMP production in BON-1 A-D. (n=3) and QGP-1 E-H. cells (n=3), without or with treatment with 5-aza-dC (BON-1: 100 nM, QGP-1: 50 nM), VPA (BON-1 2.5 mM, QGP-1: 1 mM), or their combination.